- |||||||||| PD-1-KO-T cell injection / Chengdu MedGenCell
Trial completion date, Trial primary completion date, PD(L)-1 Biomarker, IO biomarker, Metastases: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - Aug 5, 2019
P1, N=12, Active, not recruiting,
Active, not recruiting --> Completed Trial completion date: Jun 2019 --> Jan 2020 | Trial primary completion date: Jun 2019 --> Aug 2018
- |||||||||| PD-1-KO-T cell injection / Chengdu MedGenCell
Trial completion date, Trial primary completion date, PD(L)-1 Biomarker, IO biomarker, Metastases: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - Jan 23, 2019
P1, N=12, Active, not recruiting,
Trial completion date: Jun 2019 --> Jan 2020 | Trial primary completion date: Jun 2019 --> Aug 2018 Trial completion date: Dec 2018 --> Jun 2019 | Trial primary completion date: Dec 2018 --> Jun 2019
- |||||||||| PD-1-KO-T cell injection / Chengdu MedGenCell
Enrollment closed, Trial completion date, Trial primary completion date, PD(L)-1 Biomarker, IO biomarker, Metastases: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - Sep 19, 2018
P1, N=12, Active, not recruiting,
Trial completion date: Dec 2018 --> Jun 2019 | Trial primary completion date: Dec 2018 --> Jun 2019 Recruiting --> Active, not recruiting | Trial completion date: Apr 2018 --> Dec 2018 | Trial primary completion date: Apr 2018 --> Dec 2018
- |||||||||| PD-1 knockout engineered T cells / Chengdu MedGenCell
Enrollment open, PD(L)-1 Biomarker, IO biomarker, Metastases: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - Nov 22, 2016
P1, N=15, Recruiting,
Recruiting --> Active, not recruiting | Trial completion date: Apr 2018 --> Dec 2018 | Trial primary completion date: Apr 2018 --> Dec 2018 Not yet recruiting --> Recruiting
|
